Dynamic Biosensors is a company providing analytical systems for the characterization of biomolecules and molecular interactions. Founded in 2012 and headquartered in Munich, Germany, the company offers instruments and consumables for advanced analysis of biomolecular interactions on biochips and single cells. This capability enables breakthroughs in drug discovery, life science research, and cell & gene therapies. The company has gained recognition in the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. Dynamic Biosensors has seen a growth in its investment, with its Series A investment taking place on 01 March 2016 and being funded by UVC Partners. Supporting its global presence, the company operates not only in Germany but also has offices in the United States, the United Kingdom, France, Poland, Portugal, Japan, and Singapore. Dynamic Biosensors' commitment to providing instruments and consumables for the advanced analysis of biomolecular interactions positions it as a significant player in the biotechnology industry, continually attracting interest from investors and stakeholders. For more information, visit Dynamic Biosensors homepage.
No recent news or press coverage available for Bruker Biosensors.